Krintafel Coupon & Prices
Get notified when Krintafel medication is added to NiceRxGet Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
Is NiceRx a Krintafel coupon provider?
NiceRx is not a Krintafel coupon, Krintafel discount card, or Krintafel copay card provider. We do not offer Krintafel manufacturer coupons, Krintafel discounts, rebates, Krintafel savings cards, trial offers, or free Krintafel samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Krintafel patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Krintafel cheaper if I have insurance?
How much does Krintafel cost without insurance?
Without insurance, Krintafel’s costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Krintafel oral tablets 150 mg will cost around $45 for 2 tablets.
How much does Krintafel cost with insurance?
The copay for Krintafel will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Krintafel?
Krintafel is an FDA (U.S. Food and Drug Administration) approved medication manufactured by GlaxoSmithKline. It is an antimalarial drug used for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years of age and older who are receiving appropriate antimalarial therapy, such as chloroquine for acute P. vivax infection.
What doses of Krintafel are available?
Krintafel is available in tablet form, in the following doses:150 mg.
You must be tested for glucose-6-phosphate dehydrogenase (G6PD) deficiency before being prescribed Krintafel. Pregnancy testing is recommended for females of reproductive potential before starting treatment.
The recommended dose for patients aged 16 years of age and older is a single dose of 300 mg, as two 150-mg tablets taken together, with food. Coadminister Krintafel on the first or second day of the appropriate antimalarial therapy for acute P. vivax malaria.
Always speak with a healthcare professional for medical advice about any changes to your dose so they can monitor and evaluate your condition.
Krintafel active ingredients
The active ingredient of Krintafel is tafenoquine.
Krintafel side effects
The most common side effects of Krintafel in clinical trials include:
- Dizziness, nausea, vomiting, headache
- Decreased hemoglobin
In rare instances, Krintafel can cause more serious side effects. These can include:
- Hemolytic Anemia
- Serious psychiatric adverse reactions
- Hypersensitivity reactions
Your doctor will assess the benefits of using Krintafel against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions to Krintafel to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Krintafel drug interactions
Krintafel can interact with other medications. These include:
- Avoid coadministration with medicines that are substrates of organic cation transporter-2 or multidrug and toxin extrusion transporters
This list is not exhaustive and other prescription drugs may interact with Krintafel.
You should not use Krintafel if you:
- Are allergic to the active ingredient tafenoquine, primaquine, or other 8-aminoquinolines
- Have had an allergic reaction to any of the other ingredients in Krintafel
- Have G6PD deficiency or unknown G6PD status
- Are pregnant or are planning to become pregnant – Females of reproductive potential are advised to use effective contraception for 3 months after the last dose
Talk to your doctor before using Krintafel if you:
- Are taking any of the medications that could interact with Krintafel
- Are breastfeeding or are planning to breastfeed – do not breastfeed a G6PD-deficient infant or infant with unknown G6PD status for 3 months after the last dose
Krintafel is the trademark brand name for tafenoquine manufactured by GlaxoSmithKline (GSK). A generic version of tafenoquine is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Krintafel savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.